Home ›› Tools ›› Author Institution Mapping

Select the journal to see authorsí institution mapping (AIM) for the latest issue
Select journal
Indian Journal of Cancer

Table of Contents RSS Feed
2017| December  | Volume 54 | Issue 5  

Please wait, loading Google Map...

REVIEW ARTICLES  
Oncogenic drivers in nonsmall cell lung cancer and resistance to epidermal growth factor receptor tyrosine kinase inhibitors p. 1
A Pathak, S Rajappa, A Gore
[ABSTRACT]  [HTML Full text]  [PDF]
Epidermal growth factor receptor mutation testing: From conventional to real-time diagnosis of lung cancer p. 9
T Raja, NK Warrier
[ABSTRACT]  [HTML Full text]  [PDF]
Epidermal growth factor receptor T790M mutation: A major culprit in the progression of epidermal growth factor receptor-driven non-small cell lung cancer and the role of repeat biopsy p. 15
S Aggarwal, S Patil, N Rohtagi
[ABSTRACT]  [HTML Full text]  [PDF]
Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients p. 25
DC Doval, R Deshpande, B Dhabhar, KG Babu, K Prabhash, R Chopra, PV Sripada, C Deshmukh, M Suryavanshi
[ABSTRACT]  [HTML Full text]  [PDF]
Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An expert opinion p. 31
Suresh H Advani, Hemant Malhotra, Raju Titus Chacko, Maheboob Basade, Pavithran Keechilat, PN Mahapatra, Chanchal Goswami, TP Sahoo, Chirag Shah
[ABSTRACT]  [HTML Full text]  [PDF]
Role of epidermal growth factor receptor-tyrosine kinase inhibitors in the management of central nervous system metastases in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer patients p. 37
U Batra, N Lokeshwar, S Gupta, P Shirsath
[ABSTRACT]  [HTML Full text]  [PDF]
Epidermal growth factor receptor T790M testing in progressed lung cancer: A review of sensitive methods for analysis of tissue and liquid biopsy samples p. 45
A Chougule, S Basak
[ABSTRACT]  [HTML Full text]  [PDF]
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients p. 55
B Biswas, N Ghadyalpatil, MV Krishna, J Deshmukh
[ABSTRACT]  [HTML Full text]  [PDF]
CASE REPORT Top
Importance of repeat tissue biopsy and tissue-based epidermal growth factor receptor T790M testing in progressed nonsmall cell lung carcinoma patients upon negative plasma genotyping for selection of third-generation tyrosine kinase inhibitor therapy: A case study p. 65
R Mistry, A Patil
[ABSTRACT]  [HTML Full text]  [PDF]